Interview with Farzana Azam (Sciex) on recent technological developments in large molecule bioanalysis

We caught up with Farzana at the recent 10th WRIB meeting. In this video interview Farzana discusses the shift in bioanalysis towards large molecule quantitation, and consequently Pharma/CRO companies’ evolving needs in order to accommodate these changes.

She highlights recent technological developments in bioanalysis of large molecules from SCIEX, including the novel BioBA Solution with the Biomek automation workstation, and highlights it’s use in a collaborative program with QPS.

Also in this interview Farzana outlines some of the benefits of adopting hybrid LBA/ LC–MS technology for bioanalysis and comments on the future progress of LC–MS in large molecule quantification.